Charles River Laboratories | Nettoeinkommen

Aktienkurs
189.21
Täglich Wechseln
5.51 3.00%
Monatlich
-12.71%
Jährlich
15.52%
Q1 Prognose
183.40




Nettoeinkommen Veränderung Datum
Agilent USD 434M 98M 2025-09
Align Technology USD 135.76M 79.01M 2025-12
Bio-Rad Laboratories USD 317.8M 253.8M 2025-06
Bruker USD -62.4M 70M 2025-09
Cardinal Health USD 467M 17M 2025-12
Charles River Laboratories USD 54.42M 2.1M 2025-09
Cigna USD 1.23B 55.22B 2025-12
CVS Health USD -3.98B 5B 2025-09
Danaher USD 1.2B 289M 2025-12
Dentsply International USD -427M 382M 2025-09
Elevance Health USD 547M 642M 2025-12
Galapagos EUR -202.11M 96.36M 2025-09
Hologic USD 179.1M 8.2M 2025-12
Humana USD 195M 350M 2025-09
Illumina USD 334M 184M 2025-12
Incyte USD 424.17M 19.17M 2025-09
IQVIA Holdings USD 514M 183M 2025-12
Laboratory Of America USD 261.1M 23.2M 2025-09
Lonza CHF 307M 22M 2024-12
McKesson USD 1.19B 76M 2025-12
Merck EUR 902M 250M 2025-09
Mettler Toledo International USD 285.76M 68.27M 2025-12
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Quest Diagnostics USD 245M 37M 2025-09
Revvity USD 46.65M 7.3M 2025-09
Thermo Fisher Scientific USD 1.96B 348M 2025-12
United Therapeutics USD 338.7M 29.2M 2025-09
UnitedHealth USD 10M 2.34B 2025-12
Waters USD 148.92M 1.81M 2025-09
West Pharmaceutical Services USD 140M 8.2M 2025-09


Charles River Laboratories Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.